The relation between plasma apelin 36 and insulin resistance in obese type 2 diabetic Egyptian population

Figures & data

Table 1. Comparison between studied groups according to the different adipokines.

	Obese		Group III (Control) (n = 30)	Test of sig.	p
	Group I (DM) (n = 30)	Group II (Non DM) (n = 30)
Leptin (ng/ml)
Min. – Max.	6.0–100.0	10.0–100.0	2.0–25.0	^KWχ^2 = 40.141	<0.001***
Mean ± SD.	37.67 ± 27.93	41.60 ± 26.30	10.02 ± 7.53
Median	28.0	34.0	7.10
Sig. bet. grps.	I-III***, II-III***
Adiponectin (ng/ml)
Min. – Max.	2.50–30.0	5.20–35.0	12.0–65.0	^KWχ^2 = 10.904	0.004**
Mean ± SD.	15.43 ± 7.54	15.02 ± 6.94	20.20 ± 9.47
Median	13.50	13.75	20.0
Sig. bet. Grps	I-III**, II-III**
Apelin (ng/ml)
Min. – Max.	0.60–1.60	0.50–1.0	0.40–0.90	F = 27.232	<0.001***
Mean ± SD.	1.0 ± 0.28	0.75 ± 0.15	0.60 ± 0.18
Median	1.0	0.7	0.6
Sig. bet. Gps	I-II***, I-III***, II-III*

F: F test (ANOVA), Sig. bet. grps was done using Post Hoc Test (Scheffe).

*Statistically significant at p ≤ 0.05.

**Statistically significant at p ≤ 0.01.

***Statistically significant at p ≤ 0.00.

Figure 1. Correlation between apelin with fasting serum insulin (µIU/mL) in non diabetic group.

Figure 2. Correlation between apelin with HOMA-IR in non diabetic group.